Wang Xiaolin 4
4 · Revolution Medicines, Inc. · Filed Jun 22, 2022
Insider Transaction Report
Form 4
Wang Xiaolin
See Remarks
Transactions
- Sale
Common Stock
2022-06-17$17.75/sh−665$11,803→ 31,970 total
Footnotes (3)
- [F1]Pursuant to an automatic sell-to-cover imposed by the terms of the restricted stock units ("RSUs") award, the shares were sold following the vesting of the RSUs solely to cover applicable withholding taxes.
- [F2]Includes 937 shares acquired under the Issuer's Employee Stock Purchase Plan on May 31, 2022.
- [F3]Includes 26,450 RSUs.